Skip to content

An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause

An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05617287
Enrollment
42
Registered
2022-11-15
Start date
2022-09-03
Completion date
2023-01-01
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause, Menopause Related Conditions, Perimenopausal Disorder

Keywords

Menopause, Perimenopause

Brief summary

A combination of synergistic dietary supplements is hypothesized to significantly improve self-reported measures of menopausal symptoms when compared with a baseline without the intervention.

Interventions

DIETARY_SUPPLEMENTSemaine Menopause Supplement

Synergistic Dietary Supplement

Sponsors

Citruslabs
CollaboratorINDUSTRY
Semaine Health
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 57 Years
Healthy volunteers
Yes

Inclusion criteria

* Ability to take oral medication and be willing to adhere to the dietary supplement regimen (1 capsule per day) * Moderate self-reported discomfort related to perimenopause or menopause. Participants will complete the menopause well-being survey and must answer an average of moderate or higher.

Exclusion criteria

* Current use of medication for high blood pressure or for blood thinning * Currently undergoing chemotherapy or has previously been treated for cancer * Pregnancy, breastfeeding, or attempting to become pregnant during the study * Known allergic reactions to components of the dietary supplement (red clover extract, olive extract, bergamot extract )

Design outcomes

Primary

MeasureTime frameDescription
Changes in perceived discomfort associated with the most common symptoms linked with perimenopause and menopause12 weeksSymptoms will be reported by the participant on a scale of perceived discomfort and will include rankings for mood, anxiety, fatigue, sleep quality, hot flashes, and libido. This survey will be based on the widely used and validated Menopause Rating Scale (MRS). The MRS will be modified to increase dynamic range by changing the response gradations from 5 to 7.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026